CONCERN FOUNDATION 2018 – 2020 CONquer canCER Now GRANT RECIPIENTS
May 2018 - On April 28th, Concern Foundation’s Scientific Review Committee co-chaired by Anat Epstein M.D., Ph.D. of Children’s Hospital Los Angeles and Jennifer Grandis M.D. of the University of California, San Francisco met in Los Angeles. The twenty-two seasoned researchers on the committee discussed proposals submitted by the thirty-eight finalists. This cycle, we received a record-breaking, six hundred and forty-one proposals.
With the recommendations from the committee meeting, our board of directors approved the top fifteen researchers for the 2018-2020 grant cycle, during their June meeting. As a result, each researcher will be funded with $60,000 for their first year and if approved, a second year of $60,000 will be granted.
We congratulate the following up and coming researchers on their excellent proposals and look forward to groundbreaking findings:
Lukas Edward Dow Ph.D. - Joan & Sanford I. Weill Medical College of Cornell University
Colon Cancer: Targeting cancer-specific vulnerabilities in the WNT pathway
Moshe Elkabets Ph.D. - Ben-Gurion University of the Negev
Ovarian Cancer - Molecular Mechanisms: Underlying the molecular mechanisms of resistance of PI3Ka in ovarian cancer
Robert Babak Faryabi Ph.D. - University of Pennsylvania School of Medicine Breast Cancer Epigenetic mechanisms
Breast Cancer: Notch-driven Epigenetic Program of Triple-Negative Breast Cancer
Lydia Finley Ph.D. - Memorial Sloan-Kettering Cancer Center
Pancreatic Cancer & Cancer Metabolism: p53-driven a-ketoglutarate accumulation promotes tumor suppression
Malay Haldar MD., PhD. - The Trustees of the University of Pennsylvania Malignant
Sarcoma & Immune evasion by cancer: Targeting tumor-infiltrating antigen presenting cells for immunotherapy
Tae-Hee Kim Ph.D. - The Hospital for Sick Children (Toronto, Canada)
Gastric (i.e. stomach) Cancer Epigenetics: Epigenetic mechanisms of gastric tumorigenesis
Antonis Kourtidis Ph.D. - Medical University of South Carolina
Colon Cancer/miRNA: The Adherens Junctions orchestrate a tumor suppressing program via RNAi
Philip Kranzusch Ph.D.: Dana-Farber Cancer Institute
Any Cancer/Immunotherapy: Mechanism of human cGAS–DNA recognition and antitumor immune activation
Selma Masri Ph.D. - The Regents of the University of California (Irvine)
Lung Cancer and the environment effect on cancer: Circadian Sphingosine Signaling mediates Tumor/Host Crosstalk
Sara Meyer Ph.D. - Thomas Jefferson University
Leukemia (AML): Deciphering Non-Coding RNA Signaling in Acute Myeloid Leukemia
Anoop Patel M.D. - University of Washington
Brain Cancer (glioblastoma): Modeling intratumoral heterogeneity in glioblastoma using brain organoids
Yuliya Pylayeva-Gupta Ph.D. - The University of North Carolina at Chapel Hill
Pancreatic Cancer: Role of IL35 in immunotherapy resistance in pancreatic cancer
Boyang Wu Ph.D. - Washington State University
Prostate Cancer/Tumor Microenvironment: Dissecting stromal signals to target prostate cancer microenvironment
Yanzhong Yang M.D., Ph.D. - Beckman Research Institute of the City of Hope
Breast Cancer/Tumor Metabolism: Targeting Metabolic Pathways in Breast Cancer
Franklin Zhong Ph.D. - Institute of Medical Biology, Biomedical Sciences Institute, A*STAR (Singapore)
Skin Cancer & Cancer cell death mechanism: Pharmacologic inflammasome activation to treat SCCs
